Abstract | BACKGROUND: METHODS: This randomised control trial was conducted in four phases with calcium acetate or calcium carbonate. Sixty-four patients on haemodialysis were randomly divided into 2 groups. After a washout period of 2 weeks, each group was given calcium acetate or calcium carbonate for 2 months. After another washout period the patients were crossed over and again received these drugs for 2 months. Serum Calcium, phosphate, and albumin were analysed on Selectra E auto analyser at completion of each phase of study. Hypercalcaemic effect was defined as serum calcium > 2.54 mmol/l, and phosphate binding power as serum phosphate < 1.61 mmol/l. RESULTS: CONCLUSIONS:
|
Authors | Imran Saif, Abdul Halim, Ashfaq Altaf, Mohsin Saif, Muhammad Khalid, Dilshad Ahmad, Humera Imran |
Journal | Journal of Ayub Medical College, Abbottabad : JAMC
(J Ayub Med Coll Abbottabad)
2007 Oct-Dec
Vol. 19
Issue 4
Pg. 26-8
ISSN: 1025-9589 [Print] Pakistan |
PMID | 18693591
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Acetates
- Buffers
- Calcium Compounds
- Chelating Agents
- Calcium Carbonate
- calcium acetate
|
Topics |
- Acetates
(therapeutic use)
- Adolescent
- Adult
- Aged
- Buffers
- Calcium Carbonate
(therapeutic use)
- Calcium Compounds
(therapeutic use)
- Chelating Agents
(therapeutic use)
- Cross-Over Studies
- Female
- Humans
- Hypercalcemia
(etiology, prevention & control)
- Hyperphosphatemia
(etiology, prevention & control)
- Kidney Failure, Chronic
(complications, therapy)
- Male
- Middle Aged
- Renal Dialysis
(adverse effects)
|